Basel Medical Group Ltd Ordinary Shares (BMGL) — Cash Flow Reinvestment Rate
Basel Medical Group Ltd Ordinary Shares (BMGL) has a Cash Flow Reinvestment Rate of 0.01x as of June 2024, reinvesting $15.84K (capex $7.92K plus investments $-7.92K) from operating cash flow of $2.51 Million. Check BMGL cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Basel Medical Group Ltd Ordinary Shares Cash Flow Reinvestment Rate (2022–2024)
Historical reinvestment intensity for Basel Medical Group Ltd Ordinary Shares across 3 annual periods. Explore investment intensity of Basel Medical Group Ltd Ordinary Shares to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Basel Medical Group Ltd Ordinary Shares (2022–2024)
Year-by-year capital reinvestment analysis for Basel Medical Group Ltd Ordinary Shares. For live market cap and broader valuation context, see BMGL stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.01x | $15.84K | $2.51 Million | $7.92K | ▲ +33.2% |
| 2023 | 0.00x | $12.32K | $2.60 Million | $6.16K | ▼ -92.5% |
| 2022 | 0.06x | $176.99K | $2.79 Million | $88.50K | — |